FDA approves use of electronic chips in medications

August 1, 2012 by Bob Yirka report
Image: Proteus Digital Health

(Medical Xpress) -- The Food and Drug Administration in the United States has approved a request by Proteus Digital Health to allow for the inclusion of tiny digestible microchips into medicines to assist health care workers in monitoring intake of medicines by patients. Previously, the FDA had allowed such microchips only in placebo products. Proteus, the maker of the chips, plans to market them to drug manufactures who can then imbed them in individual pills that allow for electronic reporting to doctors letting them know if and when patients take their medicines.

The microchip, which is described as about the size of a grain of sand, is made of copper, and silicon, reacts with stomach juices when swallowed along with a pill. Upon reaction, it sends a signal to a patch the patient has applied to their skin where it is relayed to a smartphone. The then relays the information to the doctor’s office, allowing physicians to track how well a patient adheres to instructions on when and how often they are to take their meds. Proteus insists the aim is not to prod doctors and nurses into becoming nagging nannies, but to provide information that allows doctors to modify the types of medications they prescribe and the schedules to which the patients are asked to follow. Once the has done its job, it dissolves and passes out of the body along with other digested food.

The new technology is being pushed forward by recent reports that have found that just half of all patients take their medicines the way they are supposed to, which of course can reduce their effectiveness. Proteus believes some patients can benefit more than others from the microchips, such as those that take medicines to ward off tuberculosis, diabetics and elderly patients who have difficulty remembering to take their pills or if they’ve already taken them. Making things even more difficult, some have a whole list of with different schedules for each. The next logical step would of course be to allow the patient access to the data or to have it routed to a device set near where they keep their medicine, which would both alert them when it’s time to take their meds and to let them know if they can’t remember if they took them or not.

Some suggest this move by the FDA is the first of many likely to come over the next few years, as other technology is waiting in the wings. Coming soon may be swallowed or implanted devices that dose us automatically, sensors that report on other bodily activities, or devices that swim around in our bloodstream monitoring conditions and cleaning out plaque deposits.

Explore further: British pharmacy chain announces roll-out of new smart pills loaded with microchip

More information: proteusdigitalhealth.com/

Related Stories

British pharmacy chain announces roll-out of new smart pills loaded with microchip

January 18, 2012
(Medical Xpress) -- A new pharmaceutical program that many Britons might find literally hard to swallow, has been announced. Pharmacy chain Lloydspharmacy has partnered with American technology firm Proteus Biomedical to ...

Novartis drug investigated after 11 deaths

January 20, 2012
A multiple sclerosis drug made by industry giant Novartis is under investigation after at least 11 patients taking the medicine died.

Wireless medical monitors set to transform patient care

March 23, 2012
It's hard to find a better example of how technology is revolutionizing patient care than the tiny edible sensor Proteus Biomedical of Redwood City, Calif., plans to begin selling this fall in the United Kingdom.

FDA cites higher death risk in Sanofi drug study

July 22, 2011
(AP) -- Federal health regulators are warning doctors that a heart drug from Sanofi was associated with fatal heart problems in a recently halted company study.

Recommended for you

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

Fentanyl drives rise in opioid-linked deaths in U.S.

August 31, 2017
(HealthDay)—Fentanyl, a synthetic narcotic, is a key player in America's continuing epidemic of opioid-related overdose deaths, two new studies report.

Eating triggers endorphin release in the brain

August 28, 2017
Finnish researchers have revealed how eating stimulates brain's endogenous opioid system to signal pleasure and satiety.

Cholesterol-lowering drugs may fight infectious disease

August 21, 2017
That statin you've been taking to lower your risk of heart attack or stroke may one day pull double duty, providing protection against a whole host of infectious diseases, including typhoid fever, chlamydia, and malaria.

Data revealed under FOI shows benefits of multiple sclerosis drug currently blocked by regulators

August 17, 2017
A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

3 comments

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
1 / 5 (1) Aug 01, 2012
Do we really need to be monitored externally and internally?
IronhorseA
not rated yet Aug 01, 2012
Do we really need to be monitored externally and internally?

That's a question only your proctologist can answer. ;P
DarkHorse66
not rated yet Aug 06, 2012
Big Brother is watching You ;]

This is definitely getting closer to George Orwell's dystopia, '1984'

Cheers DH66

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.